THE DIAGNOSIS AND TREATMENT OF FUNCTIONAL CONSTIPATION IN PREGNANT WOMEN


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

The paper considers criteria for the diagnosis of functional constipations and principles in their treatment during pregnancy. Great attention is given to the choice of drug therapy in the context of its safety for a fetus and its impact on the course of pregnancy. The data by Russian and foreign authors are given, which support the efficacy and safety of lactulose during pregnancy. The results of interviews of 1082 physicians participating in the management of pregnant women are presented, which show that about 40% of the specialists prefer effective and safe lactulose preparations.

Texto integral

Acesso é fechado

Sobre autores

N. CHUKHAREVA

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: extralab@mail.ru

E. USHKALOVA

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

A. BEVZ

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Bibliografia

  1. Емельянова С. И., Котлукова Т.В. Применение лактулозы в хирургической практике // Фарматека. — 2003. — № 15. — С. 16—21.
  2. Подзолкова Н.М., Назарова С. В. Клиническое значение запоров в развитии осложнений беременности и послеродового периода // Consilium medicum. — 2010. — № 6. — С. 50—54.
  3. Рациональная фармакотерапия в акушерстве, гинекологии и неонатологии: Руководство для практических врачей. — 2-е изд., испр. и доп. В 2 т. — Т. 1. Акушерство, неонатология / Под общей ред. В.Н. Серова, Г.Т. Сухих. — М.: Литтерра, 2010.
  4. Рекомендации Института Американской гастроэнтерологической ассоциации по медикаментозному лечению заболеваний желудочно-кишечного тракта у беременных // Клин. гастроэнтерол. и гепатол. Русское издание. - 2008. - Т. 1, № 6. - С. 426-431.
  5. Сокур Т.Н., Дубровина Н.В. Применение препарата Нормазе у беременных с запорами // Трудный пациент. - 2009. - № 1—2. - С. 38—41.
  6. Шульпекова Ю.О. Запор: дифференциальный диагноз и лечение. // Справочник поликлинического врача. -2006. - Т. 4, № 8. - С. 3—9.
  7. Acsl N., Banhidy F., Puho E.H., Czeizel A.E. No association between severe constipation with related drug treatment in pregnant women and congenital abnormalities in their offspring: A population-based case-control study // Congenital Anomalies. - 2010. - Vol. 50. - Р. 15-20.
  8. Acsl N., Banhidy F., Puho E.H., Czeizel A.E. Senna treatment in pregnant women and congenital abnormalities in their offspring--a population-based case-control study // Reprod. Toxicol. - 2009. - Vol. 28, № 1. - Р.100—104.
  9. Figueroa R. Uterine rupture associated with castor oil ingestion // J. Matern. Fetal. Neonatal. Med. - 2003. -№ 13. - Р. 133—134.
  10. Jewell D.J., Young G. Interventions for treating constipation in pregnancy // Cochrane Database Syst. Rev. - 2001. -Vol. 2. - CD001142.
  11. Lachgar M., Morer I. Etude de I’efficacite et de la tolerance du lactulose dans la constipation chez la femme enceinte // Rev. Fr. Qynecol. Obstet. - 1985. - № 80. - Р. 663—665.
  12. Mahadevan U., Kane S. American Gastroenterological Association Institute medical position statement on the use of gastrointestinal medications in pregnancy // Gastroenterology. - 2006. - Vol. 131, № 1. - Р. 278—282.
  13. Muller M., Jaquenoud E. Treatment of constipation in pregnant women. A multicenter study in a gynecological practice // Schweiz. Med. Wochenschr. - 1995. - V. 125, № 36. - Р. 1689—1693.
  14. Neri I., Blasi I., Castro P. et al. Polyethylene glycol electrolyte solution (Isocolan) for constipation during pregnancy: an observational open-label study // J. Midwifery Womens Health. - 2004. - Vol. 49, № 4. - Р. 355-358.
  15. Ponce J., Martinez B., Fernandez A. et al. Constipation during pregnancy: a longitudinal survey based on self-reported symptoms and the Rome II criteria // Eur. J. Gastroenterol Hepatol. - 2008. - Vol. 20, № 1 - Р. 56—61.
  16. Sicuranza G.B., Hasler W.L. The irritable bowel syndrome during pregnancy // Gastroenterol. Clin. North. Am. - 2003. - № 32. - Р. 385—406.
  17. Suhonen R., Kantola I., Bjorksten F. Anaphylactic shock due to ingestion of psyllium laxative // Allergy. - 1983. -№ 38. - Р. 363-365.
  18. Tytgat G.N., Heading R.C., Müller-Lissner S. et al. Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting // Aliment. Pharmacol. Ther. - 2003. -Vol. 18, № 3. - Р. 291—301.
  19. Vaswani S.K., Hamilton R.G., Valentine M.D. et al. Psyllium laxative-induced anaphylaxis, asthma, and rhinitis. // Allergy. - 1996. - № 51. - Р. 266—268.
  20. Vazquez J.C. Constipation, haemorrhoids, and heartburn in pregnancy // Clinical Evidence. - 2008. - P. 1411.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Bionika Media, 2011

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies